Head of Financial Partnering for Genomic Platforms

Wellcome Sanger Institute; Cambridge; Hybrid; GBP 95.000 - 119.000; Vollzeit

Zusammenfassung

The Wellcome Sanger Institute is seeking a Head of Financial Business Partnering for Scientific Platform Services to guide investment, resources and service delivery that support our scientific mission.

Reporting to the CFO, you will lead a small team of finance business partners across Genomic Platforms, Cellular Platforms, and Technical Development & Scale-Up, managing a ~£15 million annual budget and partnering with senior leaders to balance cost, capacity and scientific needs.

Qualifikationen

• Advanced budgeting and forecasting knowledge with scenario modelling.
• Experience in pricing and standard costing models in complex environments.
• Ability to influence senior leaders and build trusted relationships.
• Experience leading and developing finance teams.
• Strong financial modelling skills using Excel and BI tools.
• Experience with governance and robust financial controls.

Aufgaben

• Guide senior leaders on financial planning, modelling, and capital investment.
• Develop costing and pricing models for internal and external services.
• Translate data into performance measures and recommendations.
• Shape proposals and support negotiations with cross-functional teams.
• Lead, coach and develop finance business partners.
• Improve processes, reporting, and governance controls.

Kenntnisse

Budgeting

Forecasting

Scenario modelling

Pricing models

Costing

Leadership

Stakeholder management

Financial modelling

Excel

Dashboards

Jobbeschreibung

The Wellcome Sanger Institute is seeking a Head of Financial Business Partnering for Scientific Platform Services to guide investment, resources and service delivery that support our scientific mission.

Reporting to the CFO, you will lead a small team of finance business partners across Genomic Platforms, Cellular Platforms, and Technical Development & Scale-Up, managing a ~£15 million annual budget and partnering with senior leaders to balance cost, capacity and scientific needs.